Transitional cell carcinoma metastatic: Which Medications Are Safest? (66 Drugs Compared)
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
66 medications are used for Transitional cell carcinoma metastatic, with 1,060 combined adverse event reports. The most reported drugs for Transitional cell carcinoma metastatic are ENFORTUMAB VEDOTIN-EJFV and PEMBROLIZUMAB.
1,060
Total Reports
66
Drugs Used
All Medications for Transitional cell carcinoma metastatic Ranked by Safety Reports
| Drug | Brand | Reports | Deaths (all) | Hosp. (all) | Death Rate |
|---|---|---|---|---|---|
| ENFORTUMAB VEDOTIN-EJFV | - | 390 | 747 | 1,149 | 20.0% |
| PEMBROLIZUMAB | KEYTRUDA | 245 | 15,543 | 35,472 | 18.6% |
| AVELUMAB | BAVENCIO | 144 | 861 | 1,630 | 23.7% |
| GEMCITABINE | Gemcitabine | 128 | 5,142 | 12,268 | 16.4% |
| ATEZOLIZUMAB | Tecentriq Hybreza | 125 | 8,520 | 15,094 | 25.3% |
| ENFORTUMAB VEDOTIN | PADCEV EJFV | 123 | 278 | 645 | 19.5% |
| CARBOPLATIN | Carboplatin | 76 | 12,544 | 35,869 | 14.9% |
| CISPLATIN | CISplatin | 64 | 8,387 | 17,469 | 17.7% |
| NIVOLUMAB | OPDIVO | 51 | 23,086 | 36,530 | 26.3% |
| PACLITAXEL | PACLITAXEL PACLITAXEL | 25 | 12,030 | 31,638 | 15.6% |
| IPILIMUMAB | YERVOY | 24 | 8,043 | 17,031 | 22.0% |
| SACITUZUMAB GOVITECAN | TRODELVY | 24 | 353 | 530 | 28.0% |
| DOCETAXEL | Docetaxel | 21 | 6,068 | 13,463 | 9.3% |
| SACITUZUMAB GOVITECAN-HZIY | - | 21 | 796 | 868 | 21.6% |
| ERDAFITINIB | BALVERSA | 18 | 315 | 226 | 28.5% |
| ENFORTUMAB VEDOTIN\ENFORTUMAB VEDOTIN-EJFV | - | 17 | 34 | 45 | 24.3% |
| CABOZANTINIB | - | 13 | 767 | 2,771 | 20.0% |
| DOXORUBICIN | Doxorubicin Hydrochloride | 7 | 15,653 | 28,630 | 18.9% |
| METHOTREXATE | Methotrexate | 7 | 21,265 | 68,793 | 8.4% |
| GUADECITABINE | - | 6 | 29 | 52 | 35.8% |